Print• Half-Year Review
• US Biotech Financings
• Performance of US IPOs
• Data Transparency
• Breakthrough Therapies
• Unconventional Deal Structures
• VC Dollars Flow to Biotech
• H1 Advancers & Decliners
• Top Financings in H1
• Top M&A and Partnering in H1
• June Financings
• June Advancers & Decliners
• June M&A and Partnering
• Clinical Trials
• Patents Issued
• PDUFA Dates
• New Drug Approvals
• Burrill Indicies
July 25, 2013
http://www.burrillreport.com/article-the_august_2013_issue_of_the_burrill_report.html
.gif)
